Reperfusion delays increase mortality riskA Quebec study has shown many myocardial infarction patients are receiving reperfusion therapy outside recommended time windows, and this is putting them at increased risk of dying within 30 days. Don’t forget fibratesA major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization. 2010 Canadian hypertension guidelines now available Consider panic in unexplained chest pain cases Warfarin patients often outside therapeutic range Smoking cancels benefit of alcohol on stroke risk Pneumococcal vaccine doesn’t reduce cardiac risk More patients reach LDL goals with rosuvastatin combo Aortic calcium indicates cardiac risk Stenting staves off amputation in critical limb ischemia Drug-eluting devices offer a new option for patients ineligible for vascular surgery First Previous 82 83 84 85 86 Next Last
